Tech Company Financing Transactions
Aktiia Funding Round
On 5/2/2025, Aktiia landed $42 million in Series B funding from Earlybird Venture Capital, Wellington Partners and K Fund.
Transaction Overview
Company Name
Announced On
5/2/2025
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series B
Investors
Earlybird Venture Capital (Lead Investor) (Christoph Massner)
Wellington Partners (Lead Investor) (Johannes Fischer)
Proceeds Purpose
The investment will accelerate the company's mission to manage the world's blood pressure.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Rue du Bassin 8a
Neuchâtel, 2000
Switzerland
Neuchâtel, 2000
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
At Aktiia, we harness the power of data to inform and engage people with hypertension and to enable physicians to deliver more targeted and timely care. Our engineers, scientists, and mission-driven visionaries utilize unique datasets and deep learning algorithms, advancing beyond conventional blood pressure metrics to redefine proactive health standards.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mattia Bertschi
Chief Financial Officer
Mathieu Danthony
Chief Medical Officer
Jay Shah
Chief Technical Officer
Josep Solà
President
Daniel Graf
VP - Regulatory Affairs
Neil Puri
Browse more venture capital transactions:
Prev: 5/2/2025: Suite Studios venture capital transaction
Next: 5/2/2025: Doppel venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs